Phase II Clinical Study of LTC004 in Patients With Advanced Sarcoma
NCT06384248
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Unresectable or Metastatic Sarcoma
Interventions
DRUG:
LTC004
Sponsor
Letolab